Skip to content
Citation only via OpenAlex

P3‐151: mTOR regulates chaperone networks and cognitive outcomes in mice modeling Alzheimer's disease

Anson P. Pierce, Natalia Podlutskaya, Verónica Galván

Alzheimer s & Dementia · 2011

Abstract

Alzheimer's disease (AD) is anage-dependent neurodegenerative condition that has in common with other neurodegenerations the accumulation and aggregation of misfolded proteins, which in the case of AD is represented by a wide range of aggregates ofamyloid-ß (Aß) peptides. The target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (TOR) pathway is a majorsignaling hub that integrates nutrient/growth factor availability with cell metabolism. Reduced activity of the TOR pathway extends invertebrate lifespan, and, in mice, pharmacologic reduction of TOR signaling during adulthood extends life and strongly inhibits mTOR function in brain. We recently showed that systemic, long-term inhibition of mTOR by rapamycin lowers Aß levels and preserves learning and memory in transgenic mice modeling AD. To determine the mechanisms by which inhibition of mTOR modulates histopathological and cognitive outcomes in AD we performed proteomic and gene expression studies in brain tissues of control orrapamycin-treated PDAPP transgenic mice. A large proportion of protein supregulated in rapamycin-treated transgenic brains were members of the chaperone family of proteins, of which many are induced by cellular stress. Heat shock proteins and chaperones promote proteostasis(definition) by assisting in the proper folding of proteins or in their targeting for degradation. The master transcriptional regulator of heat shock proteins is heat shock factor 1 (HSF1), which is negatively regulated by TOR. HSF1 is required for lifespan extension and conversely, its overexpression is sufficient to extend longevity in Celegans. Consistent with the observed up regulation of heat shock proteins in rapamycin-treated transgenic brains, we found that phosphorylation of HSF1 at Ser326, which is associated with increased transcriptional activity, was significantly elevated in rapamycin-treated brain tissues. In contrast, phosphorylation of HSF1 at Ser330, which inhibits transcriptional activity, was unchanged by rapamycin treatment. Examination of brain sections byimmunohistochemistry revealed that activated HSF1 was preferentially increased and was Tran located to the nucleus of granular cells in hippocampal dentate gyrus. Maintenance of proteostasis may be sufficient to prevent Aß accumulation and improve cognitive outcomes in mice modeling AD. We will report on the requirement for enhanced proteostasis for the reduction in Aß levels and the preservation of cognitive function in PDAPP transgenic animals producing high levels of amyloid.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.jalz.2011.05.1591
Canonical
link ↗
Fetched
2026-10-07 MST

Cite this

APA
Pierce, A.P., Podlutskaya, N., &amp; Galván, V. (2011). P3‐151: mTOR regulates chaperone networks and cognitive outcomes in mice modeling Alzheimer's disease. <em>Alzheimer s & Dementia</em>. https://doi.org/10.1016/j.jalz.2011.05.1591
Vancouver
Pierce AP, Podlutskaya N, Galván V. P3‐151: mTOR regulates chaperone networks and cognitive outcomes in mice modeling Alzheimer's disease. Alzheimer s & Dementia. 2011. doi:10.1016/j.jalz.2011.05.1591.
BibTeX
@article{anson2011PmTORr, title = {P3‐151: mTOR regulates chaperone networks and cognitive outcomes in mice modeling Alzheimer's disease}, author = {Anson P. Pierce and Natalia Podlutskaya and Verónica Galván}, journal = {Alzheimer s & Dementia}, year = {2011}, doi = {10.1016/j.jalz.2011.05.1591}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings